EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieLeitlinieOpen Access · CC BY 4.0

Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study

Naomi Hasegawa, Hiroyuki Muraoka, Yusuke Arai iD, Toru Horinouchi, Kazuhiro Yamamuro, Naoki Hashimoto, Shinichiro Ochi, Takashi Tsuboi, Yasushi Kawamata, Toshinori Nakamura, Yuka Yasuda iD, Junya Matsumoto und 9 weitere

Neuropsychopharmacology Reports · 2025-12 · 45 (4)

DOI: 10.1002/npr2.70067 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 28.10.2025. Verfasst von Naomi Hasegawa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Major Depressive Disorder, Schizophrenia, Guideline Adherence. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Health and Labor Sciences Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The Effectiveness Research on the Dissemination and Education of Psychiatric Clinical Practice Guidelines (EGUIDE Project) was launched in Japan to promote guideline‐adherent treatment for schizophrenia and major depressive disorder (MDD) through educational outreach programs. Although short‐term effects on participating physicians have been reported, the long‐term and facility‐wide effects remain unclear. This study evaluated whether guideline‐compliant treatment behaviors improved across institutions over time, indicating potential diffusion or spillover effects.

Methods

We conducted a prospective observational study involving 298 psychiatric facilities between 2016 and 2023. Discharge prescriptions and treatment data were collected for 19 623 patients with schizophrenia and 9805 patients with MDD. Adherence to the guidelines was assessed using 11 schizophrenia quality indicators (QI‐S) and seven MDD quality indicators (QI‐D). We performed logistic regression analyses, adjusting for age, sex, and facility type, with Bonferroni correction for multiple comparisons.

Results

For schizophrenia, significant year‐on‐year improvements were observed in seven of the 11 QI‐S, including assessment of treatment‐resistant schizophrenia (TRS) diagnosis (from 42.2% to 62.5%), use of modified electroconvulsive therapy (mECT; from 6.1% to 11.8%), and nonprescription of anticholinergics (from 70.7% to 81.7%). For MDD, three of the seven QI‐D showed improvement, including assessment of severity diagnosis (from 51.2% to 77.0%) and use of mECT (from 12.8% to 26.6%). Notably, the implementation of cognitive behavioral therapy (CBT) decreased. These findings suggest long‐term behavioral changes across all facilities, extending even to nonparticipating clinicians.

Conclusion

The presence of EGUIDE‐trained psychiatrists was associated with sustained improvements in guideline‐compliant treatments at the institutional level. These results imply not only individual educational benefits but also a diffusion of practice culture—that is, a spillover effect—leading to enhanced quality of psychiatric care. Continued educational efforts are essential to improving treatment practices at scale. Trial Registration The protocol for the EGUIDE Project is registered with the University Hospital Medical Information Network Registry (UMIN000022645)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderSchizophreniaGuideline AdherenceHumansMaleFemaleMiddle AgedJapanAdultProspective StudiesPractice Guidelines as TopicHospitals, Psychiatric

Stichwörter der Autor:innen

evidence practice gapguidelinemajor depressive disorderquality indicatorsschizophrenia

Autor:innen und Institutionen

  • Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Department of Psychiatry, Kitasato University, School of Medicine, Sagamihara, Kanagawa, Japan.
  • Department of Community Mental Health, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  • Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
  • Center for Health Control, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Psychiatry, Nara Medical University, School of Medicine, Kashihara, Nara, Japan.

ORCID-Profile: Yusuke Arai, Yuka Yasuda, Satsuki Ito, Toshiaki Onitsuka, Kazutaka Ohi, Hikaru Hori

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Health and Labor Sciences Research
  • The Japanese Society of Neuropsychopharmacology
  • The Japanese Society of Mood Disorders
  • The Japanese Society of Clinical Neuropsychopharmacology
  • The Japanese Society of Psychiatry and Neurology

Zitieren

APA

Hasegawa, N., Muraoka, H., Arai, Y., Horinouchi, T., Yamamuro, K., Hashimoto, N., Ochi, S., Tsuboi, T., Kawamata, Y., Nakamura, T., Yasuda, Y., Matsumoto, J., Ito, S., Onitsuka, T., Ohi, K., Numata, S., Hori, H., Inada, K., Watanabe, K., …, & Hashimoto, R. (2025). Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study. Neuropsychopharmacology Reports, 45(4). https://doi.org/10.1002/npr2.70067

Vancouver

Hasegawa N, Muraoka H, Arai Y, Horinouchi T, Yamamuro K, Hashimoto N, et al. Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study. Neuropsychopharmacology Reports. 2025;45(4). doi:10.1002/npr2.70067

BibTeX
@article{Hasegawa2025,
  author = {Hasegawa, Naomi and Muraoka, Hiroyuki and Arai, Yusuke and Horinouchi, Toru and Yamamuro, Kazuhiro and Hashimoto, Naoki and Ochi, Shinichiro and Tsuboi, Takashi and Kawamata, Yasushi and Nakamura, Toshinori and Yasuda, Yuka and Matsumoto, Junya and Ito, Satsuki and Onitsuka, Toshiaki and Ohi, Kazutaka and Numata, Shusuke and Hori, Hikaru and Inada, Ken and Watanabe, Koichiro and Yasui-Furukori, Norio and Hashimoto, Ryota},
  title = {Long‐Term Impact of EGUIDE Training on Facility‐Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study},
  journal = {Neuropsychopharmacology Reports},
  year = {2025},
  volume = {45},
  number = {4},
  doi = {10.1002/npr2.70067}
}
Kostenlos starten →